CytomX Therapeutics (CTMX) Depreciation and Depletion (2016 - 2017)
CytomX Therapeutics' (CTMX) quarterly Depreciation and Depletion came in at $400000.0 in Q4 2017, down 20.0% YoY from $500000.0 in Q4 2016, and up 8.7% on a QoQ basis from $368000.0 in Q3 2017.
CytomX Therapeutics (CTMX) Depreciation and Depletion (2016 - 2017) Analysis & Trends
CytomX Therapeutics (CTMX) has 2 years of Depreciation and Depletion data on file, last reported at $400000.0 in Q4 2017.
- Quarterly Depreciation and Depletion fell 20.0% year-over-year to $400000.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $1.7 million (changed N/A YoY) and the FY2025 annual result came in at $1.2 million, down 25.0% from the prior year.
- Depreciation and Depletion climbed to $400000.0 in Q4 2017, from $368000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $500000.0 in Q4 2016 to a low of $368000.0 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 38.91 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | CytomX Therapeutics | 732.14 Mn | 401.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 400,000.00 |
| Dec 31, 2017 | 400,000.00 |
| Sep 30, 2017 | 368,000.00 |
| Sep 30, 2017 | 368,000.00 |
| Dec 31, 2016 | 500,000.00 |
| Dec 31, 2016 | 500,000.00 |
| Sep 30, 2016 | 443,000.00 |
| Sep 30, 2016 | 443,000.00 |